Navigation Links
Veracyte, Inc. Announces Second Quarter 2014 Financial Results
Date:8/13/2014

id Association guidelines for a molecular test to help patients avoid unnecessary surgery following an indeterminate thyroid nodule FNA biopsy result.
  • Reached more than 135 million covered lives for the Afirma GEC, including new positive coverage decisions from three Blue Cross Blue Shield-affiliated plans.
  • Gained a positive coverage decision from our first managed-Medicaid plan – AmeriHealth Caritas – an increasingly important avenue of reimbursement for the Afirma GEC.
  • Launched our Afirma Malignancy Classifiers – comprised of tests for medullary thyroid cancer and to assess BRAF mutational status – and secured New York State regulatory approval, making our comprehensive Afirma solution available to patients nationwide.
  • Presented strong preliminary data at the American Thoracic Society's 2014 international conference in May for a molecular classifier to improve early, non-surgical diagnosis of idiopathic pulmonary fibrosis.
  • 2014 Financial Outlook The company reiterates its 2014 revenue guidance of $38 million to $43 million. The forecast for the number of FNAs is being revised to a range of 66,000 to 73,000 samples from a range of 76,000 to 83,000 samples. The GEC test rate is expected to come in at the top of the guided range of 20% to 22%, with the number of GEC-only tests higher than expected due to growing adoption by large institutional accounts. 

    Conference Call/Webcast DetailsVeracyte will host a conference call and webcast today at 5 p.m. Eastern Time to discuss the company's financial results and provide a general business update. The webcast and subsequent replay may be accessed by visiting Veracyte's website at http://investor.veracyte.com. Please connect to the company's website at least 15 minutes prior to the webcast to ensure adequate time for any necessary software download. Alternatively, please call (855) 541-0980 (U.S.)
    '/>"/>

    SOURCE Veracyte
    Copyright©2014 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Veracyte, Inc. to Host Conference Call and Webcast to Discuss Second Quarter 2014 Financial Results on August 13, 2014
    2. Veracyte, Inc. Announces Third Quarter 2013 Financial Results
    3. Veracyte, Inc. to Announce Third Quarter 2013 Financial Results and Host Conference Call on Monday, November 25, 2013
    4. Veracyte, Inc. Announces Pricing of Initial Public Offering
    5. Hanger Announces Appointment of Asif Ahmad to Board of Directors
    6. BiOptix Announces Additional $1.4M in Funding to Aid in Commercialization and Working Capital Needs
    7. Perrigo Company plc Announces Quarterly Dividend
    8. Kindred Biosciences Announces Second Quarter 2014 Financial Results
    9. Imprimis Pharmaceuticals Announces Second Quarter 2014 Financial Results and Provides Operational Update
    10. WuXi PharmaTech Announces Second-Quarter 2014 Results
    11. Nutrastar International Inc. Announces Second Quarter 2014 Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/30/2014)... WuXi PharmaTech (Cayman) Inc. (NYSE: WX ), a ... the pharmaceutical, biotechnology, and medical device industries, with operations ... the United States , today announced the establishment ... Aviv area of Israel.  ... integrated R&D services to local customers. It will also ...
    (Date:10/30/2014)... Mass. , Oct. 30, 2014 Boston ... to participate in the 2014 Credit Suisse Annual Healthcare ... Phoenix , AZ.  Dan Brennan , executive ... presentation about the company beginning at approximately 8:00 a.m. ... A live webcast of the presentation and question ...
    (Date:10/30/2014)... 2014   ViaDerma, Inc. (OTCQB: VDRM), ... products to market, has recently released a revolutionary ... a topical liquid tetracycline-based antibiotic that uses a ... oral medication active ingredients into topical drugs. The ... antibiotic to help prevent skin infection in minor ...
    Breaking Medicine Technology:WuXi AppTec Launches Representative Office in Israel, Forms Strategic Collaboration with Pontifax 2Boston Scientific To Participate In 2014 Credit Suisse Annual Healthcare Conference 2ViaDerma, Inc. Lead Product TetraStem Shown Effective in Fighting Staph Infections including MRSA 2ViaDerma, Inc. Lead Product TetraStem Shown Effective in Fighting Staph Infections including MRSA 3
    (Date:10/31/2014)... 2014 (HealthDay News) -- Obesity increases the risk of ... Hispanic women, two new U.S. studies show. One ... overweight or obese increased the risk for estrogen receptor-negative ... "We,ve known this for a long time for white ... Hispanic women," study author Esther John, a senior research ...
    (Date:10/31/2014)... have invented a lab device to give cancer researchers ... that tumor cells spread through the body, causing more ... on precisely how tumor cells travel, the device could ... The inventors, from the university,s Whiting School of Engineering ... images from their new system recently in the journal ...
    (Date:10/31/2014)... Beach, Florida (PRWEB) October 31, 2014 ... or, the “Company”) today announced it has signed a ... Canada-based companies in the urban cultivation sector - Urban ... (BC Northern Lights”), and W3 Metal Inc. (“W3 Metal” ... the “Target Companies”). Pursuant to the LOI and ...
    (Date:10/31/2014)... October 31, 2014 In an effort to ... Dr. Majid Jamali announced he will soon offer orthodontics at ... the end of November. , To build upon the ... of New York has become known for, Dr. Jamali is ... from such top learning institutions as UCLA, Stanford and UCSF. ...
    (Date:10/31/2014)... Uniwigs.com newly arrived flip in hair ... can comfortably attach itself around people’s heads with a transparent ... of flip-in extensions comes with adjustable loops, which are improved ... and customers can now adjust the wire to best fit ... apply this new generation of flip ins, they simply need ...
    Breaking Medicine News(10 mins):Health News:Study Confirms Obesity-Breast Cancer Link for Blacks, Hispanics 2Health News:Viewing cancer on the move: New device yields close-up look at metastasis 2Health News:Viewing cancer on the move: New device yields close-up look at metastasis 3Health News:Urban Hydroponics Inc. Signs Definitive Agreement to Merge with Canadian Hydroponics Companies 2Health News:Urban Hydroponics Inc. Signs Definitive Agreement to Merge with Canadian Hydroponics Companies 3Health News:Urban Hydroponics Inc. Signs Definitive Agreement to Merge with Canadian Hydroponics Companies 4Health News:Urban Hydroponics Inc. Signs Definitive Agreement to Merge with Canadian Hydroponics Companies 5Health News:Oral & Maxillofacial Surgery of New York Adds Orthodontic Patient Services 2Health News:Oral & Maxillofacial Surgery of New York Adds Orthodontic Patient Services 3Health News:UniWigs Unveiles New Generation of Flip In Hair Extensions 2
    ... Depressed heart attack patients have a higher risk for sudden ... team led by researchers from Washington University School of Medicine ... many years. , "There,s a two- to four-fold increase in ... they also happen to be depressed," says Robert. M. Carney, ...
    ... United,States has been fortifying some foods with folic acid (the ... public health effort to prevent neural,tube defects in newborns. The ... down by 30%. But there,s also evidence that the added ... issue of,Harvard Women,s Health Watch., In the early years ...
    ... BUFFALO, N.Y. -- Entrenched sedentary behavior such as watching ... bane for years of parents of overweight children and ... has been little scientifically based research on the effect ... researchers now have shown in a randomized trial that ...
    ... Tamoxifen may ease condition,s mania phase, but side effects could ... News) -- A drug commonly used to treat breast cancer ... "high" phase experienced by people with bipolar disorder, researchers say. ... experienced a significant lessening of their mania compared to people ...
    ... BIRMINGHAM, Ala., March 3 Emageon Inc.,(Nasdaq: ... technology,systems for hospitals, healthcare networks and imaging facilities ... will present at the,Raymond James 29th Annual Institutional ... Regency Grand Cypress, Orlando, Florida. Emageon will,present on ...
    ... March 3 the U.S. Supreme Court,issued a 4-4 decision ... they are injured by a drug. Prior to this decision ... had ruled in favor of,Michigan plaintiffs, declaring that drug companies ... FDA. With the tie vote in the,U.S. Supreme Court, the ...
    Cached Medicine News:Health News:Clinical depression raises risk of death for heart attack patients years after attack 2Health News:Clinical depression raises risk of death for heart attack patients years after attack 3Health News:Folic Acid in the Food Supply Reduces Birth Defects, but May Cause Extra Cancers, Reports the Harvard Women's Health Watch 2Health News:Restricting kids' video time reduces obesity, randomized trial shows 2Health News:Breast Cancer Drug Might Treat Bipolar Disorder 2Health News:Breast Cancer Drug Might Treat Bipolar Disorder 3
    ... The cost-effective line of compact CO2 ... units feature an extremely accurate laser beam, ... lasers are especially advantageous for small operating ... office sites. Use of special contact tips ...
    ... ideal for small clinics and offices. Based ... combines the advantages of laser precision and ... Novapulse system delivers short-duration, high amplitude pulses ... is allowed to cool thus minimizing charring ...
    ... MD Super Pulse sealed CO2 surgical lasers ... by the experience and support services of ... surgical laser experience. All settings are available ... Ultra MD Super Pulse surgical lasers are ...
    ... System is a Q-switched 532 Nd Yag ... fluid output, lowering intraocular pressure. The Selecta ... produces a 3-nanosecond high-energy beam of light, ... as traditional argon laser therapy (ALT), but ...
    Medicine Products: